{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:25:03Z","timestamp":1789503903678,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005937","name":"Cheng Hsin General Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.phymed.2019.152946","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T13:36:13Z","timestamp":1557322573000},"page":"152946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1"],"prefix":"10.1016","volume":"62","author":[{"given":"Lie-Chwen","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Chien","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Shin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2699-116X","authenticated-orcid":false,"given":"Young-Ji","family":"Shiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-6836","authenticated-orcid":false,"given":"Hui-Kang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2019.152946_bib0001","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMsa1213829","article-title":"Achievement of goals in U.S. diabetes care, 1999-2010","volume":"368","author":"Ali","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2019.152946_bib0002","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s12272-013-0224-1","article-title":"New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study","volume":"36","author":"Almasri","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.phymed.2019.152946_bib0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jyp.2012.09.002","article-title":"Anti-diabetic activity of active fractions of stereospermum tetragonum DC and isolation of active principles","volume":"5","author":"Bino Kingsley","year":"2013","journal-title":"J. Young Pharm."},{"key":"10.1016\/j.phymed.2019.152946_bib0004","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12906-016-1382-8","article-title":"The ethyl acetate fraction of corn silk exhibits dual antioxidant and anti-glycation activities and protects insulin-secreting cells from glucotoxicity","volume":"16","author":"Chang","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.phymed.2019.152946_bib0005","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1073\/pnas.0610173104","article-title":"A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db\/db mice","volume":"104","author":"Chen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2019.152946_bib0006","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00125-015-3805-3","article-title":"Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in rodent models","volume":"59","author":"Chen","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.phymed.2019.152946_bib0007","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4093\/dmj.2016.40.2.99","article-title":"An update on the effect of incretin-based therapies on beta-cell function and mass","volume":"40","author":"Chon","year":"2016","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.phymed.2019.152946_bib0008","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1013302231549","article-title":"WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability","volume":"21","author":"Dalvit","year":"2001","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.phymed.2019.152946_bib0009","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00125-016-3942-3","article-title":"Changes in beta cell function occur in prediabetes and early disease in the Lepr (db) mouse model of diabetes","volume":"59","author":"Do","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.phymed.2019.152946_bib0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/07853890510037400","article-title":"The GLP-1 system as a therapeutic target","volume":"37","author":"Edwards","year":"2005","journal-title":"Ann. Med."},{"key":"10.1016\/j.phymed.2019.152946_bib0011","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/diabetes.50.10.2244","article-title":"Phosphorylation-dependent nucleocytoplasmic shuttling of pancreatic duodenal homeobox-1","volume":"50","author":"Elrick","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.phymed.2019.152946_bib0012","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/pr.115.011395","article-title":"Glucagon-like peptide-1 and its class B G protein-coupled receptors: a long march to therapeutic successes","volume":"68","author":"Graaf","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phymed.2019.152946_bib0013","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1463-1326.2004.00430.x","article-title":"Function of a long-term, GLP-1-treated, insulin-secreting cell line is improved by preventing DPP IV-mediated degradation of GLP-1","volume":"7","author":"Green","year":"2005","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phymed.2019.152946_bib0014","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jdi.12420","article-title":"Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus","volume":"7","author":"Groeneveld","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.phymed.2019.152946_bib0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/aps.2011.146","article-title":"Glucagon-like peptide 1 receptor plays a critical role in geniposide-regulated Ins secretion in INS-1 cells","volume":"33","author":"Guo","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2019.152946_bib0016","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/fcp.12231","article-title":"Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways","volume":"31","author":"Hu","year":"2017","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152946_bib0017","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2146\/ajhp150990","article-title":"Role of glucagon-like peptide 1 receptor agonists in management of obesity","volume":"73","author":"Isaacs","year":"2016","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.phymed.2019.152946_bib0019","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4093\/dmj.2014.38.6.426","article-title":"Therapeutic approaches for preserving or restoring pancreatic beta-cell function and mass","volume":"38","author":"Jung","year":"2014","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.phymed.2019.152946_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/171742","article-title":"Medicinal Plants Qua Glucagon-like peptide-1 secretagogue via intestinal nutrient sensors","volume":"2015","author":"Kim","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.phymed.2019.152946_bib0021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1467-789X.2005.00159.x","article-title":"Adiponectin: action, regulation and association to Ins sensitivity","volume":"6","author":"Lihn","year":"2005","journal-title":"Obes. Rev."},{"key":"10.1016\/j.phymed.2019.152946_bib0022","first-page":"77","article-title":"New phenylpropanoid glycoside from Boschniakia rossica","volume":"56","author":"Lin","year":"2004","journal-title":"Chin. Pharm. J."},{"key":"10.1016\/j.phymed.2019.152946_bib0023","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1211\/jpp.58.1.0016","article-title":"The inhibitory effect of phenylpropanoid glycosides and iridoid glucosides on free radical production and beta2 integrin expression in human leucocytes","volume":"58","author":"Lin","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152946_bib0024","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cellbi.2003.10.004","article-title":"N-acetyl-GLP-1: a DPP IV-resistant analogue of glucagon-like peptide-1 (GLP-1) with improved effects on pancreatic beta-cell-associated gene expression","volume":"28","author":"Liu","year":"2004","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.phymed.2019.152946_bib0025","series-title":"Compounds and Their Use has GLP-1 Receptor Regulatory Activity. CN105622687B","author":"Liu","year":"2018"},{"key":"10.1016\/j.phymed.2019.152946_bib0026","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1515\/revneuro-2015-0005","article-title":"Neuroprotective effects of geniposide on Alzheimer's disease pathology","volume":"26","author":"Liu","year":"2015","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.phymed.2019.152946_bib0027","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.2337\/db13-1563","article-title":"Chronic reduction of GIP secretion alleviates obesity and Ins resistance under high-fat diet conditions","volume":"63","author":"Nasteska","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.phymed.2019.152946_bib0028","series-title":"Novo Nordisk successfully Completes the First Phase 3a Trial, PIONEER 1, With Oral Semaglutide","author":"Nordisk","year":"2018"},{"key":"10.1016\/j.phymed.2019.152946_bib0029","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.phymed.2019.152946_bib0030","doi-asserted-by":"crossref","first-page":"E318","DOI":"10.1152\/ajpendo.00191.2010","article-title":"GLP-1 treatment reduces endogenous Ins resistance via activation of central GLP-1 receptors in mice fed a high-fat diet","volume":"299","author":"Parlevliet","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2019.152946_bib0031","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1210\/jc.2003-030513","article-title":"Ghrelin levels correlate with Ins levels, Ins resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans","volume":"88","author":"Purnell","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2019.152946_bib0032","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1371\/journal.pbio.0060037","article-title":"Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of Ins resistance","volume":"6","author":"Tanabe","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.phymed.2019.152946_bib0033","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tem.2016.03.004","article-title":"Glucagon-like peptide 1 analogs and their effects on pancreatic islets","volume":"27","author":"Tuduri","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2019.152946_bib0034","article-title":"Exendin-4 upregulates adiponectin level in adipocytes via Sirt1\/Foxo-1 signaling pathway","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2019.152946_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/709893","article-title":"Small molecule drug discovery at the glucagon-like peptide-1 receptor","volume":"2012","author":"Willard","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.phymed.2019.152946_bib0036","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/aps.2008.17","article-title":"Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin","volume":"30","author":"Wu","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2019.152946_bib0037","series-title":"Flora of Taiwan","author":"Yang","year":"1998"},{"key":"10.1016\/j.phymed.2019.152946_bib0038","doi-asserted-by":"crossref","first-page":"e1746","DOI":"10.1038\/cddis.2015.107","article-title":"Geniposide promotes beta-cell regeneration and survival through regulating beta-catenin\/TCF7L2 pathway","volume":"6","author":"Yao","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phymed.2019.152946_bib0039","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1087057114561950","article-title":"Emergence of Chinese drug discovery research: impact of hit and lead identification","volume":"20","author":"Zhou","year":"2015","journal-title":"J. Biomol. Screen"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711319301151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711319301151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:18:54Z","timestamp":1760552334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711319301151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":38,"alternative-id":["S0944711319301151"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2019.152946","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2019.152946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152946"}}